| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.039 | 0.4 |